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Ticks and tick-borne pathogens affect health and welfare of companion animals
worldwide, and some human tick-borne diseases are associated with exposure
to domestic animals. Vaccines are the most environmentally friendly alternative to
acaracides for the control of tick infestations, and to reduce the risk for tick-borne
diseases affecting human and animal health. However, vaccines have not been
developed or successfully implemented for most vector-borne diseases. The main
limitation for the development of effective vaccines is the identification of protective
antigens. To address this limitation, in this study we used an experimental approach
combining vaccinomics based on transcriptomics and proteomics data with vaccination
trials for the identification of tick protective antigens. The study was focused on
Ixodes ricinus and Dermacentor reticulatus that infest humans, companion animals
and other domestic and wild animals, and transmit disease-causing pathogens. Tick
larvae and adult salivary glands were selected for analysis to target tick organs and
developmental stages playing a key role during tick life cycle and pathogen infection
and transmission. Two I. ricinus (heme lipoprotein and uncharacterized secreted
protein) and five D. reticulatus (glypican-like protein, secreted protein involved in
homophilic cell adhesion, sulfate/anion exchanger, signal peptidase complex subunit
3, and uncharacterized secreted protein) proteins were identified as the most effective
protective antigens based on the criteria of vaccine E > 80%. The putative function
of selected protective antigens, which are involved in different biological processes,
resulted in vaccines affecting multiple tick developmental stages. These results
suggested that the combination of some of these antigens might be considered to
increase vaccine efficacy through antigen synergy for the control of tick infestations
and potentially affecting pathogen infection and transmission. These antigens were
proposed for commercial vaccine development for the control of tick infestations in
companion animals, and potentially in other hosts for these tick species.
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INTRODUCTION
Tick-borne pathogens cause medically important infections
affecting dogs and other pet species worldwide (Liu et al.,
2018; Skotarczak, 2018), and some human tick-borne diseases
are associated with exposure to domestic animals (Estrada-Peña
et al., 2008; Kwit et al., 2018; Escárcega-Ávila et al., 2019). The
tick species (Acari: Ixodidae), Ixodes ricinus (Linnaeus, 1758) and
Dermacentor reticulatus (Fabricius, 1794) infest humans, pets and
other domestic and wild animals. I. ricinus transmits disease-
causing pathogens such as Borrelia spp. (Lyme disease and
various borreliosis), tick-borne encephalitis virus (TBEV; tick-
borne encephalitis) and Anaplasma phagocytophilum (human
and animal anaplasmosis) while D. reticulatus is a vector for
Francisella tularensis (tularemia), Rickettsia spp. (human and
animal rickettsiosis), Omsk hemorrhagic fever virus (OHFV;
Omsk hemorrhagic fever), and Babesia canis (canine babesiosis)
(Glickman et al., 2006; de la Fuente et al., 2008, 2015;
Beugnet and Marié, 2009).
Vaccines have not been developed or successfully
implemented for most vector-borne diseases (VBD) affecting
humans and animals (de la Fuente et al., 2017b). Therefore,
reduction of arthropod vector infestations is important for the
control of VBD (de la Fuente and Kocan, 2003; Sperança and
Capurro, 2007; Karunamoorthi, 2011; Coller et al., 2012; de la
Fuente and Contreras, 2015; de la Fuente et al., 2017b; de la
Fuente, 2018). Traditional control methods for arthropod vector
infestations are based on the use of chemical acaricides with
associated drawbacks such as selection of arthropod-resistant
strains and contamination of both the environment and animal
products (de la Fuente and Kocan, 2003; de la Fuente et al.,
2017b). Vaccination is an environmentally friendly alternative
for the control of vector infestations and pathogen infections
that allows control of several VBD by targeting their common
vector (de la Fuente et al., 2007, 2011, 2017b; de la Fuente and
Contreras, 2015; de la Fuente, 2018). Vaccines could be developed
to target different tick developmental stages and functions on
various hosts with the advantage of avoiding environmental
contamination and selection of pesticide resistant arthropod
vectors while improving animal welfare and production (de la
Fuente et al., 2017b; de la Fuente, 2018). The experience with the
only commercial vaccines available for the control of ectoparasite
infestations, TickGard and Gavac, demonstrated that these
vaccines contribute to the control of cattle tick populations while
reducing acaricide applications, but were difficult to introduce
into the market because of the absence of immediate effect
on tick infestations and the application in combination with
other control measures (de la Fuente and Kocan, 2003, 2006;
Willadsen, 2004; de la Fuente et al., 2007). The hypothesis
behind tick vaccine protective capacity is that ticks feeding on
immunized hosts ingest antibodies specific for the target antigen
that could reduce its levels and biological activity and/or interact
with conserved epitopes in other proteins resulting in reduced
tick feeding, development and reproduction (de la Fuente et al.,
2011, 2017b; Moreno-Cid et al., 2011; de la Fuente, 2018).
The limiting step in developing tick vaccines is the
identification of protective antigens (de la Fuente and Kocan,
2003; de la Fuente et al., 2018). Recent developments in
omics analyses of both ticks and tick-borne pathogen and the
application of systems biology to the study of tick-host-pathogen
molecular interactions have advanced our understanding of the
genetic factors and molecular pathways involved at the tick-host,
tick-pathogen and host-pathogen interface (de la Fuente, 2012;
de la Fuente et al., 2017a). These technologies are generating
extensive information, but algorithms are needed to use these
data for advancing knowledge on basic biological questions
and the discovery of candidate protective antigens for the
development of improved vaccines for the control of ticks and
VBD (de la Fuente and Merino, 2013; de la Fuente et al., 2016,
2018; Contreras et al., 2018).
Acaricides have been effectively used to reduce tick
infestations in companion animals (Otranto, 2018). However,
ticks and transmitted pathogens continue to be a major health
problem in dogs and other companion animals that require
the development of effective vaccines (Otranto, 2018). Previous
experiments have shown the possibility of using vaccines with
tick gut protein extracts, Subolesin/Akirin and Bm96 for the
control of Rhipicephalus sanguineus infestations in dogs (de la
Fuente et al., 2015), and with pathogen-derived antigens for the
control of VBD (e.g., Alhassan et al., 2018; Grosenbaugh et al.,
2018). Nevertheless, vaccines for the control of tick infestations
and transmitted diseases in companion animals have not been
registered and commercialized.
In this study, we used a vaccinomics approach based on
transcriptomics and proteomics data (de la Fuente and Merino,
2013; de la Fuente et al., 2016) in combination with vaccination
trials for the discovery of tick protective antigens for the control
of I. ricinus and D. reticulatus infestations in companion animals.
Dogs and rabbits were used as model animals. Tick larvae and
adult salivary glands were selected for analysis. Tick larvae are the
first developmental stage to infest hosts and acquire infection or
transmit pathogens that are transovarially transmitted. Salivary
glands produce a cocktail of anti-clotting, anti-platelet, anti-
inflammatory, vasodilatatory and immunomodulatory proteins
that interfere with host defenses to aid in tick blood feeding
and pathogen infection and transmission (Ayllón et al., 2015;
Chmelaø et al., 2016; Nuttall, 2018). The experiments resulted
in the identification of new antigens that showed a protective
efficacy of vaccination against I. ricinus and D. reticulatus
infestations in rabbits and dogs.
MATERIALS AND METHODS
Ethics Statement
White rabbits (Oryctolagus cuniculus) and Beagle dogs (Canis
lupus familiaris) were used in the experiments. Animal
experiments were conducted in strict accordance with the
recommendations of the European Guide for the Care and Use
of Laboratory Animals. Animals were housed and experiments
conducted at LLC ACRO Vet Lab (Pylipovichi village, Kiev
region, Ukraine) with the approval and supervision of the
Ukrainian Commission for Bioethics and Biosafety for animals
under the studies “Tick vaccine experiment on rabbits” number
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000369 and “Tick vaccine experiments on dogs” numbers 000576,
000577 and 000761.
Ticks and Sample Preparation
Ixodes ricinus ticks were originally obtained from the reference
laboratory colony maintained at the tick rearing facility of
the Institute of Parasitology of the Biology Centre of the
Academy of Sciences of the Czech Republic (Genomic Resources
Development Consortium, Contreras et al., 2014). D. reticulatus
ticks were obtained from a Dutch colony maintained at the
Utrecht Centre for Tick-borne Diseases (UCTD), Department
of Infectious Diseases and Immunology, Faculty of Veterinary
Medicine, Utrecht University, Utrecht, The Netherlands (Villar
et al., 2014). Tick colonies were maintained at the LLC ACRO
Vet Lab (Pylipovichi village, Kiev region, Ukraine) and used
for analysis and vaccination trials. I. ricinus unfed larvae whole
internal tissues (IL) and unfed adult salivary glands (ISG), and
D. reticulatus unfed larvae whole internal tissues (DL) and
unfed adult salivary glands (DSG) were processed. RNA and
proteins were extracted from approximately 500 larvae using
the AllPrep DNA/RNA/Protein Mini Kit (Qiagen, Valencia,
CA, United States) and from 50 salivary glands (25 females
and 25 males) using Tri Reagent (Sigma-Aldrich, St. Louis,
MO, United States) according to manufacturer instructions.
RNA was purified with the RNeasy MinElute Cleanup Kit
(Qiagen, Valencia, CA, United States) and characterized using
the Agilent 2100 Bioanalyzer (Santa Clara, CA, United States)
in order to evaluate the quality and integrity of RNA
preparations. RNA concentration was determined using the
Nanodrop ND-1000 (NanoDrop Technologies Wilmington, DE,
United States). Protein concentration was determined using the
Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL,
United States) with BSA as standard. RNA yield was 10 µg (IL),
4 µg (ISG), 3.5 µg (DL), and 6 µg (DSG). Protein yield was 8 mg
(IL and DL), 1.4 mg (ISG), and 3 mg (DSG).
Transcriptomics Data Acquisition for
I. ricinus and D. reticulatus Samples
Purified RNAs were used for library preparation using the
TruSeq RNA sample preparation kit v.1 and the standard low
throughput procedure (Illumina, San Diego, CA, United States)
as previously reported (Genomic Resources Development
Consortium, Contreras et al., 2014; Villar et al., 2014). Briefly,
1 µg total RNA was used as starting material for library
preparation with the exception of the DL sample for which 0.7 µg
were used. Messenger RNA was captured using poly-dT magnetic
beads and purified polyA+ RNA was chemically fragmented
and reverse-transcribed. Remaining RNA was enzymatically
removed, and the second strand generated following an end
repair procedure and preparation of double-stranded cDNA for
adaptor ligation. Adaptor oligonucleotides containing the signals
for subsequent amplification and sequencing were ligated to both
ends and cDNA samples were washed using AMPure SPRI-
based magnetic beads (Beckman Coulter, IZASA, Barcelona,
Spain). Adapters contained identifiers, which allow multiplexing
in the sequencing run. An enrichment procedure based on
PCR was then performed to ensure that all molecules in the
library conserved the adapters at both ends. The number of
PCR cycles was adjusted to 10 for all samples except for DL
which needed up to 15 cycles. The final amplified library was
checked again on a BioAnalyzer 2100 (Agilent, Santa Clara, CA,
United States). Libraries were titrated by quantitative PCR using
a reference standard to characterize molecule concentration
per library (IL, 5.51 nM; ISG, 62.16 nM; DL, 12.44 nM;
DSG, 100.95 nM). Libraries were denatured and seeded on the
respective lanes of the flowcells at a final concentration after re-
naturalization of 10–14 pM. IL and ISG samples were run in
single-nucleotide flowcells while DL and DSG samples were run
in double-nucleotide flowcells to allow for pair-end sequencing.
After binding, clusters were formed in the flowcells by local
amplification using a Cluster Station apparatus (Illumina).
Following sequencing primer annealing, flowcells were loaded
into a GAIIx equipment (Illumina) to perform sequencing using
the TruSeq R© system (Illumina). IL and ISG samples were run
under a 1 × 75 bp single-end read protocol while DL and DSG
samples were run under a pair-end 2 × 100 bp protocol for de
novo RNA sequencing (RNAseq). After sequencing and quality
filtering, reads were split according to their different identifiers
and fastq files were generated to proceed to quality analysis and
gene expression analysis and/or de novo transcript assembly.
Transcriptomics data was submitted to Dryad Digital Repository1
or published here (Supplementary Dataset 1) and by Villar et al.
(2014) for I. ricinus and D. reticulatus samples, respectively.
Bioinformatics for I. ricinus and
D. reticulatus Transcriptomics Data
I. ricinus
The pipeline used for bioinformatics analysis of I. ricinus
transcriptomics data was similar to that described by Twine et al.
(2011) as previously reported (Genomic Resources Development
Consortium, Contreras et al., 2014). The reads from both IL
and ISG samples were mapped to the reference I. scapularis
genome (assembly JCVI_ISG_i3_1.02) using a TopHat-Cufflinks-
Cuffdiff pipeline (Langmead et al., 2009; Trapnell et al., 2009).
Transcript abundance was estimated using Cufflinks by analyzing
the number of reads mapped to each transcript and handling
the deviations due to the sample preparation (Langmead et al.,
2009). Finally, differential expression between IL and ISG was
characterized using Cuffdiff, integrated into the Cufflinks package
(Langmead et al., 2009). For analysis of genes coding for secreted
proteins, 6 subcellular localization predictors were chosen: WoLF
PSORT3, TargetP4, Protein Prowler5, SLP-Local6, PredSL7 and
CELLO8. All these tools have web services that enable batch
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predicted secreted proteins in IL and ISG were included in
Supplementary Dataset 2.
D. reticulatus
For D. reticulatus transcriptomics data, the 21,838,507 reads
(∼2.2 Gb) in DSG were compared against the I. ricinus selected
reference gene set (Table 1) using PROmer (Kurtz et al., 2004).
The query sequences were considered in their 3 reading frames
and the reference sequences only in the frame 1. PROmer results
were filtered by selecting the hits with a minimum length of 60 bp
for the extended similarity region and a minimum identity of 80%
in this region. Reads with hits fulfilling these requirements were
clustered to the selected gene with which they have PROmer hits.
We selected the read with hits and always also its paired read.
The reads belonging to each cluster were then assembled with
Velvet (Zerbino and Birney, 2008; Zerbino et al., 2009) to produce
a set of contigs clustered to the reference genes. A BLASTX was
then done against all proteins from Ixodidae included in the nr
database. For each cluster of contigs, we chose the most similar
protein to which the contigs aligned with more similarity, and
substituted that protein as the new reference protein for that
cluster. As expected, in many cases the most similar protein was
identical to the initial I. ricinus reference protein. Differential
gene expression between DL and DSG samples was determined
using χ2 test statistics with Bonferroni correction (P = 0.05) in
the IDEG6 software9.
Proteomics Data Acquisition for I. ricinus
and D. reticulatus Samples
Proteins were resuspended in 5% SDS and frozen at −20◦C
until use. Two hundred µg of protein extracts from the four
samples, IL, ISG, DL and DSG, were mixed with the same
quantity of Laemmli sample buffer x2 and applied using a 5-
well comb on a conventional SDS-PAGE gel (1.5 mm-thick,
4% stacking, 10% resolving). The electrophoretic run was
stopped as soon as the front entered 3 mm into the resolving
gel, so that the whole proteome became concentrated in the
stacking/resolving gel interface. The unseparated protein bands
were visualized by Coomassie Brilliant Blue R-250 staining,
excised, cut into cubes (2 × 2 mm) and treated with 0.1%
RapiGest SF surfactant (Waters, Milford. MA, United States)
according to manufacturer’s protocol in order to enhance the
subsequent in-gel trypsin digestion. After RapiGest treatment,
samples were digested overnight at 37◦C with 60 ng/µl trypsin
(Promega, Madison, WI, United States) at 5:1 protein:trypsin
(w/w) ratio in 50 mM ammonium bicarbonate, pH 8.8 containing
10% (v/v) acetonitrile. The resulting tryptic peptides from each
proteome were extracted by 1 h-incubation in 12 mM ammonium
bicarbonate, pH 8.8. Trifluoroacetic acid (TFA) was added to a
final concentration of 1% and the peptides were finally desalted
onto C18 OASIS HLB extraction cartridges (Waters, Milford,
MA, United States) and dried-down prior to reverse phase
high performance liquid chromatography (RP-HPLC) method
coupled with mass spectrometry (RP-HPLC-MS/MS) analysis
using a Surveyor LC system coupled to an ion trap mass
9http://compgen.bio.unipd.it/bioinfo/software/
spectrometer model LCQ Fleet (Thermo-Finnigan, San Jose, CA,
United States). Peptides were eluted using a 180-min gradient
from 5 to 40% solvent B in solvent A (solvent A: 0.1% formic
acid in water; solvent B: 0.1% formic acid in acetonitrile).
The LCQ Fleet was programmed to perform a data-dependent
MS/MS scan on the 3 most intense precursors detected in a full
scan from 400 to 1600 amu (1 µscan, 200 ms injection time).
Protein identification was conducted using SEQUEST algorithm
(Proteome Discoverer 1.1 package, Thermo Finnigan), allowing
optional modifications in Methionine (oxidation) and Cysteine
(carboxamidomethylation). Proteomics data was included in
Supplementary Dataset 3 or published by Villar et al. (2014) for
I. ricinus and D. reticulatus samples, respectively.
Bioinformatics for I. ricinus and
D. reticulatus Proteomics Data
The MS/MS raw files were searched against the Ixodidae Uniprot
database (28,771 entries in February 2012) with the following
constraints: tryptic cleavage after Arginine and Lysine, up to two
missed cleavage sites, and tolerances of 0.5 Da for precursor
ions and 0.8 Da for MS/MS fragment ions. Protein assignations
were first filtered with a SEQUEST XCorr > 2, but only proteins
with false discovery rate (FDR) ≤ 0.01 and identified with at
least 4 peptides were selected for further analysis from the
Ixodidae database. The MS/MS data was also used to search
against the database of predicted secreted proteins encoded by
the selected top 1,000 expressed genes in both IL and ISG.
In this case, proteins with sequence span > 2% were selected
for further analysis. Differential protein representation between
L and SG samples was determined using χ2 test statistics
with Bonferroni correction (P = 0.001) in the IDEG6 software
(see footnote 9).
Gene Ontology
Gene ontology (GO) analysis for Molecular Function (MF),
Cellular Component (CC) and/or Biological Process (BP)
was conducted using the cDNA Annotation System software
(dCAS; Bioinformatics and Scientific IT Program (BSIP),
Office of Technology Information Systems (OTIS), National
Institute of Allergy and Infectious Diseases (NIAID), Bethesda,
MD, United States10), AmiGO11 and UniProt12 using non-
redundant sequence database (nr) and databases of tick-specific
sequences13,14. The GO annotations for selected candidate tick
protective antigens were included in Supplementary Dataset 4.
Cloning of I. ricinus and D. reticulatus
Genes Encoding for Candidate
Protective Antigens
First, selected I. ricinus orthologs and D. reticulatus de novo
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TABLE 1 | Selected I. ricinus genes encoding for candidate tick protective antigens.
Ixodes gene ID Genbank accession
No. for I. scapularis
Genbank accession
No. for I. ricinus
Encoded protein Expression profile Selection criteria
472 ISCW000027
XM_002433472
GFVZ01075347 Uncharacterized protein Over in IL Transcriptomics: Top
1,000 expressed genes













GFVZ01108982 Secreted protein Over in IL
869a ISCW006458
XM_002434869













than 4 peptides and












GFVZ01099159 Secreted salivary gland
peptide
Over in IL Proteomics: Search
against putative
secreted proteins
encoded by top 1,000
expressed genes in
both IL and ISG with
XCorr > 2 and
sequence span > 2%
892a ISCW002948
XM_002409892
GFVZ01048464 Gap1 Over in IL
450a ISCW018653
XM_002434450
GFVZ01135723 Vacuolar H+ ATPase Over in IL
950a ISCW013911
XM_002415950
GFVZ01068232 Hypothetical protein Over in IL
158c ISCW019448
XM_002401158
GEGO01005185 Glypican Over in IL
459 ISCW011801
XM_002411459



























GFVZ01100779 Secreted protein Over in ISG
(Continued)
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TABLE 1 | Continued
Ixodes gene ID Genbank accession
No. for I. scapularis
Genbank accession
No. for I. ricinus
Encoded protein Expression profile Selection criteria
150 ISCW006313
XM_002436150









GFVZ01163301 Secreted protein Over in ISG
971a ISCW006734
XM_002435971





Over in ISG Transcriptomics:
Biological process (BP)
GO for genes predicted
as encoding for
secreted proteins that
were among the top
1,000 expressed genes
overexpressed in ISG




GANP01009473 Solute carrier Over in ISG
490c ISCW003957
XM_002399490








GANP01011997 Sialin Over in ISG
078a ISCW005630
XM_002435078


















GFVZ01171589 Signal peptidase 12
kDa subunit
IL = ISG Transcriptomics:
Biological process (BP)
GO for genes predicted
as encoding for
secreted proteins that
were among the top
1,000 expressed genes
in both IL and ISG and







aGenes abandoned due to no amplification by RT-PCR or low expression levels in E. coli. bGenes removed from further analysis due to the GO CC prediction. cProteins
identified in the membrane fraction of IL with FDR < 0.01. IL, I. ricinus larvae and ISG, salivary glands.
or D. reticulatus sequence-specific primers and conditions
(Supplementary Table 1) using IL, ISG, DL and DSG RNA and
the iScript One-Step RT-PCR Kit with SYBR Green and the iQ5
thermal cycler (Bio-Rad, Hercules, CA, United States) following
manufacturer’s recommendations. The genes that did not
produce an amplicon after RT-PCR were eliminated from further
analyses (Tables 1, 2). Remaining coding regions for I. scapularis
sequences corresponding to selected I. ricinus orthologous
sequences and D. reticulatus de novo generated contig sequences
were synthesized (GenScript, Hong Kong) with optimized codon
usage for Escherichia coli (Supplementary Dataset 5).
Production of Recombinant Proteins and
Vaccine Formulations
For gene expression and the production of the recombinant
proteins, E. coli BL21 Star (DE3) One Shot cells (Invitrogen-
Life Technolgies, Inc., Grand Island, NY, United States)
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TABLE 2 | Selected D. reticulatus genes encoding for candidate tick protective antigens.
Dermacentor gene ID Ixodes gene ID Genbank accession No. for D. reticulatus Number of reads Expression profile (overexpressed in)
DL DSG I. ricinus D. reticulatus
S1a,c 964 MK895447 250 3206 ISG∗ DSG∗
S2 256 MK895448 881 1748 ISG∗ DSG∗
S3b 752 NA 68 82 IL DSG
S4b 178 NA 35 181 ISG∗ DSG∗
S5 892 MK895449 4 216 IL DSG
S6 912 MK895450 5 49 ISG∗ DSG∗
S7c 490 MK895451 45 2000 ISG∗ DSG∗
S8c 158 MK895452 0 34 IL DSG
S9 145 MK895453 9 49 ISG∗ DSG∗
S10c 391 MK895454 0 240 IL DSG
S11 459 MK895455 145 796 IL DSG
S12 098 MK895456 84 246 NS DSG
S13 738 MK895457 12 136 ISG∗ DSG∗
S14c 216 MK895458 3585 2088 IL∗ DL∗
S15 427 MK895459 30 702 ISG∗ DSG∗
S16 624 MK895460 49 481 NS DSG
S17c 908 MK895461 867 3972 ISG∗ DSG∗
S18c 058 MK895462 23 749 ISG∗ DSG∗
S19 950 MK895463 2 14 IL DSG
S20c 082 MK895464 67800 1839 IL∗ DL∗
S21 450 MK895465 64 105 IL DSG
S22 078 MK895466 5 27 ISG∗ DSG∗
S23c 016 MK895467 9 139 ISG∗ DSG∗
S24a 150 NA 0 1 ISG∗ DSG∗
S25 874 MK895468 2 39 ISG∗ DSG∗
S26a 529 NA 2 0 IL NS
S27a 749 NA 3 0 IL NS
∗Similar gene expression profile in I. ricinus and D. reticulatus. aGenes abandoned due to poor sequence information or low expression in E. coli. bGenes removed from
further analysis due to the GO CC prediction. cProteins identified in the membrane fraction of DL with FDR < 0.01. NA, no accession number because sequences were
not submitted due to poor sequence information or because genes were removed from further analysis due to the GO CC prediction. NS, not significant; IL, I. ricinus
larvae and ISG, salivary glands; DL, D. reticulatus larvae and DSG, salivary glands.
were transformed with the target gene cloned into the
pET101/D-TOPO expression vector (Invitrogen-Life
Technolgies). Recombinant E. coli were inoculated into
10 ml of Luria-Bertani (LB) containing 50 µg/ml ampicillin
(Sigma-Aldrich, St Louis, MO, United States) and 0.4% glucose
(Laboratorios CONDA S.A., Madrid, Spain) and kept growing
overnight at 37◦C with shaking. Two ml of the overnight
culture was propagated into 250 ml flasks containing 50 ml
LB, 50 µg/ml ampicillin and 0.4% glucose for 2 h at 37◦C
and 200 rpm, and then for 4 h after addition of 0.5 mM final
concentration of isopropyl-β-d-thiogalactopyranoside (IPTG,
Sigma-Aldrich) for induction of gene expression. The cells
were harvested by centrifugation at 3,900 × g for 15 min
at 4◦C and stored at −80◦C for protein purification. One
g of the cells harvested after induction of gene expression
were resuspended in 5 ml of lysis buffer (100 mM Tris-
HCl, pH 7.5, 250 mM NaCl, 7 M Urea, 10 mM imidazole)
containing protease inhibitor (Ref. 04693132001, Roche,
San Cugat del Vallés, Barcelona, Spain) and disrupted using
a cell sonicator (Model MS73; Bandelin Sonopuls, Berlin,
Germany). After disruption, the insoluble protein fraction
containing the recombinant antigens as inclusion bodies were
collected by centrifugation at 15,000 × g for 15 min at 4◦C
and stored at −20◦C before purification. The purification of
the recombinant protein was conducted using the automated
Maxwell 16 Polyhistidine Protein Purification Kit (Promega,
Madison, WI, United States). The eluted fraction containing
the purified denatured proteins was dialyzed against 1000
volumes of PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.8 mM KH2PO4), pH 7.4 for 12 h at 4◦C. Recombinant
proteins were then concentrated using an Amicon Ultra-
15 ultrafiltration device (cut off 10 kDa) (Millipore-Merck,
Darmstadt, Germany), and adjusted to 0.5 mg/ml. Protein
concentration was determined using bicinchoninic acid (Pierce
BCA Protein Assay Kit, Thermo Scientific, Rockford, IL,
United States). For vaccine formulation, recombinant proteins
or saline control were adjuvated in Montanide ISA 50 V2
(Seppic, Paris, France) for rabbit trials or Montanide PET
GEL A (Seppic), a ready-to-disperse polymeric adjuvant
designed to improve the safety and efficacy of vaccines for
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companion animals (Parker et al., 2009) for dog trials to a
final protein concentration of 250 µg/ml (Merino et al., 2013;
Contreras and de la Fuente, 2016, 2017).
Vaccination Trials in Rabbits
Three two-year-old rabbits per group were assigned to I. ricinus
or D. reticulatus trial injected subcutaneously (dorsum between
shoulders) at days 0 (T1) and 14 (T2) with 0.2 ml (50 µg) doses
of recombinant protein vaccine formulations or adjuvant/saline
using a syringe with removable needle (0.45 × 13 mm). Two
weeks after the last immunization (day 28; T3), rabbits in
vaccinated and control groups were infested with 200 I. ricinus
or D. reticulatus tick larvae of approximately 21 days after
hatching placed on bags located on each rabbit’s shaved ear
as described previously (Contreras and de la Fuente, 2016,
2017). Immunizations, tick larval infestations, collections and
evaluations were done blinded and the key to the experimental
groups was not disclosed until the end of the experiment.
Engorged tick larvae were collected, counted and weighted
as they dropped off between days 31 to 34. Fed larvae were
incubated at 21◦C, 80–82% humidity with 7 h dark and 17 h
light photoperiod until molting. The tick larvae successfully
molting to nymphal stage were collected and counted between
days 51 to 65. The number of engorged larvae, weight/larvae,
and percent of larvae molting to nymphs were evaluated. Data
were analyzed statistically to compare results for each tick species
between individuals fed on vaccinated and adjuvant/saline
injected control rabbits by Student’s t-test with unequal variance
(P = 0.05). Vaccine efficacy (E) was calculated as E (%) = 100
[1−(DL × DMN)], where DL is the reduction in the number
of engorged larvae and DMN is the reduction in the percent
of larvae molting to nymphs in ticks fed on vaccinated rabbits
when compared to the controls fed on adjuvant/saline injected
rabbits (Contreras and de la Fuente, 2016, 2017). Only parameters
with statistically significant differences were included in vaccine E
calculation. Results were included in Supplementary Dataset 6.
Vaccination Trials in Dogs
Three randomly mixed breed male and female dogs
(age > 6 months; body weight > 2 Kg) per group were assigned
to I. ricinus or D. reticulatus trial and injected subcutaneously
(loose skin on the side of the chest) at days 0 (T1) and 21
(T2) with 0.2 ml (50 µg) doses of recombinant protein vaccine
formulations or adjuvant/saline using a syringe with removable
needle (0.45 × 13 mm). Two weeks after the last immunization
(day 36; T3), dogs in vaccinated and control groups were infested
with I. ricinus or D. reticulatus 25:30 (female:male ratio) adults of
at least 10 days after molting and 100 nymphs of approximately
15 days after molting placed on feeding chambers (one chamber
per tick stage) glued on each dog’s shaved flank. Immunizations,
tick infestations, collections and evaluations were done blinded
and the key to the experimental groups was not disclosed until
the end of the experiment. Engorged tick females were collected,
counted and weighted as they dropped off between days 41
and 48. Fed females were incubated at 21◦C, 80–82% humidity
with 24 h dark photoperiod for approximately 1 month until
oviposition. Egg mass per tick was weighted and incubated
for fertility determined by counting the number of larvae per
tick. Engorged tick nymphs were collected and counted as they
dropped off between days 40 to 43. Detached engorged nymphs
were incubated at 21◦C, 80–82% humidity with 8 h dark and 16 h
light photoperiod until molting. The tick nymphs successfully
molting to adults were collected and counted approximately
1 month after collection. The number of engorged nymphs
and adult females, weight/female, oviposition (egg mass/tick),
fertility (No. hatching larvae), and number of nymphs molting
to adults were evaluated. Data were analyzed statistically to
compare results for each tick species between individuals fed
on vaccinated and adjuvant/saline injected control rabbits by
Chi2-test (P = 0.05). Vaccine efficacy (E) was calculated as E
(%) = 100 [1−(DN × DMA × DT × DO × DF)], where DN is
the reduction in the number of engorged nymphs, DMA is the
reduction in the number of nymphs molting to adults, DT is the
reduction in the number of engorged female ticks, DO is the
reduction in oviposition, and DF is the reduction in fertility in
ticks fed on vaccinated rabbits when compared to the controls
fed on adjuvant/saline injected dogs. Only parameters with
statistically significant differences were included in vaccine E
calculation. Results were included in Supplementary Dataset 6.
Analysis of IgG Antibody Response by
ELISA and Western Blot
In rabbits, blood samples were collected from each animal before
each immunization (T1 and T2) and tick infestation (T3). In
dogs, blood samples were collected from each animal before
each immunization (T1 and T2), tick infestation (T3) and at
day 75 (T4) to better evaluate the duration of the antibody-
mediated immune response in the major vaccine target species.
Blood samples were collected into sterile tubes and maintained
at 4 ◦C until arrival at the laboratory. Serum was then separated
by centrifugation and stored at −20◦C. An indirect ELISA test
was performed to detect IgG antibodies against recombinant
antigens in serum samples from vaccinated and control animals
collected at T1–T3 for rabbits or T1–T4 for dogs as described
previously (Merino et al., 2013; Contreras and de la Fuente,
2016, 2017). High absorption capacity polystyrene microtiter
plates were coated with 50 µl (0.02 µg/ml solution of purified
recombinant proteins) per well in carbonate-bicarbonate buffer
(Sigma-Aldrich). After an overnight incubation at 4◦C, coated
plates were blocked with 200 µl/well of blocking solution
(5% skim milk in PBS). Serum samples or PBS as negative
control were diluted (1:1000, 1:10,000, 1:100,000 v/v; optimal
dilution, 1:10,000) in blocking solution and 50 µl/well were
added into duplicate wells of the antigen-coated plates. After
an overnight incubation at 4◦C, the plates were washed three
times with a washing solution (PBS containing 0.05% Tween 20).
A goat anti-rabbit or anti-dog IgG-peroxidase conjugate (Sigma-
Aldrich) was added (diluted 1:3000 v/v in blocking solution)
and incubated at RT for 1 h. After three washes with washing
solution, 200 µl/well of substrate solution (Fast OPD, Sigma-
Aldrich) was added. Finally, the reaction was stopped with
50 µl/well of 3N H2SO4 and the optical density (OD) was
measured in an ELISA plate reader at 450 nm. Antibody levels in
vaccinated and control animals were expressed as the OD450nm
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FIGURE 1 | Tick transcriptomics and proteomics data. (A) Differential gene expression in I. ricinus larvae (L) and salivary gland (SG) samples. (B) Genes predicted by
different algorithms to encode for secreted proteins in I. ricinus larvae (IL) and salivary glands (ISG) samples. (C) Proteins identified with XCorr > 2 in the Ixodidae
database in IL, ISG, D. reticulatus larvae (DL) and salivary gland (DSG) samples. (D,E) Biological process (BP) GO for genes predicted as coding for secreted
proteins that were either (D) among the top 1,000 expressed genes in both IL and ISG or (E) overexpressed in ISG. Genes coding for hypothetical proteins or with
unknown function were excluded from the graph. The BPs selected for further analysis are marked with asterisks. (F–H) GO analysis for (F) biological process (BP),
(G) molecular function (MF) and (H) cell component (CC) of genes selected as coding for tick protective antigens. Genes coding for nuclear DNA-binding proteins
were removed from further analysis. Complete datasets are on Supplementary Datasets 1–4.
(ODanimalsera−ODPBScontrol) and compared between vaccinated
and control groups by ANOVA test (P = 0.05).
For Western blot analysis, 10 µg of selected purified
recombinant proteins and Rhipicephalus microplus Subolesin
(Merino et al., 2013) as negative control were separated by
electrophoresis in an SDS-12% polyacrylamide gel (Life Science,
Hercules, CA, United States) and transferred to a nitrocellulose
membrane. The membrane was blocked with 5% BSA (Sigma-
Aldrich) for 2 h at room temperature (RT) and washed three
times with TBS (50 mM Tris-Cl, pH 7.5, 150 mM NaCl,
0.05% Tween 20). Pooled sera collected at T3 from vaccinated
dogs were used as primary antibodies. Primary antibodies were
used at a 1:300 dilution in TBS, and the membrane was
incubated overnight at 4◦C and washed three times with TBS.
The membrane was then incubated with an anti-dog IgG-
horseradish peroxidase (HRP) conjugate (Sigma-Aldrich) diluted
1:15000 in TBS with 2% BSA. The membrane was washed four
times with TBS and finally developed with TMB (3,3′, 5,5′-
tetramethylbenzidine) stabilized substrate for HRP (Promega,
Madrid, Spain) according to the manufacturer recommendations.
Determination of mRNA Levels by
Real-Time RT-PCR
The expression of selected genes was characterized using total
RNA extracted from three separate pools of adult tick salivary
glands (25 females and 25 males each pool) and larvae (500
larvae each pool) using Tri Reagent (Sigma-Aldrich) according
to manufacturer instructions. Real-time RT-PCR was performed
on RNA samples using gene-specific oligonucleotide primers
(Supplementary Table 1) and the iScript One-Step RT-PCR
Kit with SYBR Green and the CFX96 Touch Real-Time PCR
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FIGURE 2 | Selection of genes coding for candidate I. ricinus tick protective antigens. Trascriptomics data were obtained from I. ricinus larvae (L) and salivary gland
(SG) samples followed by selection of top 1,000 most expressed genes in both samples and genes coding for secreted proteins. GO analysis for biological process
(BP) was then used to select for functionally relevant genes. Proteomics data was used for mining databases of Ixodidae and predicted secreted proteins. Selected
genes (N = 36; IDs. shown inside boxes) expressed or overexpressed (Over) in I. ricinus larvae (IL) and salivary glands (ISG) samples were finally subjected to GO
analysis for BP, molecular function (MF) and cell component (CC) to remove two genes coding for nuclear DNA-binding proteins (marked with asterisks), resulting in a
final set of 34 selected genes coding for candidate protective antigens. Complete datasets are on Supplementary Datasets 1–4.
Detection System (Bio-Rad, Hercules, CA, United States).
A dissociation curve was run at the end of the reaction to ensure
that only one amplicon was formed and that the amplicons
denatured consistently in the same temperature range for every
sample. The mRNA levels were normalized against tick ribosomal
protein S4 (rps4) as described previously using the genNorm
method (ddCT method as implemented by Bio-Rad iQ5 Standard
Edition, Version 2.0) (Ayllón et al., 2013). Normalized Ct values
were compared between salivary glands and larvae by Student’s
t-test with unequal variance (P = 0.05).
Protein Membrane Localization for
I. ricinus and D. reticulatus Candidate
Protective Antigens
To characterize the subcellular localization of proteins encoded
by selected genes, the proteomes of IL and DL were obtained
as described above but purifying membrane proteins prior
to analysis. Approximately 200 D. reticulatus and I. ricinus
larvae were pulverized in liquid nitrogen and homogenized
with a glass homogenizer (20 strokes) in 4 ml buffer (0.25 M
sucrose, 1 mM MgCl2, 10 mM Tris-HCl, pH 7.4) supplemented
with complete mini protease inhibitor cocktail (Roche, Basel,
Switzerland). Samples were sonicated for 1 min in an ultrasonic
cooled bath followed by 10 sec of vortex. After 3 cycles of
sonication-vortex, the homogenate was centrifuged at 200 × g
for 5 min at RT to remove cellular debris. The supernatant
was then centrifuged at 12000 × g for 30 min at 4◦C and
the pellet fraction enriched in crude plasma membranes was
collected, resuspended in 100 µl Laemmli sample buffer and
applied onto 1.2-cm wide wells on a 12% SDS-PAGE gel. The
MS/MS raw files were searched against the Ixodida (40,849 entries
in June 2013) Uniprot database and the protein database of
candidate protective antigens (Tables 1, 2) using the SEQUEST
algorithm (Proteome Discoverer 1.3, Thermo Scientific) with the
following constraints: tryptic cleavage after Arginine and Lysine,
up to two missed cleavage sites, and tolerances of 1 Da for
precursor ions and 0.8 Da for MS/MS fragment ions and the
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FIGURE 3 | Pipeline for the identification of tick protective antigens. The Venn diagrams depict the set of genes selected for further analysis as coding for candidate
tick protective antigens in I. ricinus and D. reticulatus. The graphs represent the vaccine E after vaccination trials in rabbits and dogs. Of the selected genes coding
for I. ricinus (N = 34) and D. reticulatus (N = 25) tick protective antigens, only 16 and 21, respectively, were produced as recombinant proteins for initial vaccination
screening in rabbits. After vaccination trial in rabbits, the criteria for the final selection of tick protective antigens for vaccination in dogs was based on vaccine
E > 40%, resulting in 4 I. ricinus and 9 D. reticulatus antigens. The vaccination trial in dogs resulted in an overall vaccine E > 80% for 216 and 391 gene antigens in
I. ricinus, and S2, S8, S17, S18, and S20 gene antigens in D. reticulatus. Full gene description and results are on Tables 1–3 and Supplementary Dataset 6.
searches were performed allowing optional Met oxidation and
Cys carbamidomethylation. A FDR < 0.01 was considered as
condition for successful peptide assignments. Results are shown
in Tables 1, 2.
RESULTS AND DISCUSSION
Algorithm for Selection of Genes
Encoding for Candidate Tick Protective
Antigens
According to Elvin and Kemp (1994) the conditions necessary
and sufficient for an effective tick protective antigen include that
(a) host antibodies should be able to gain access to the tick
antigen, (b) sufficient antibodies must gain access to the target
antigen, and (c) the formation of the antibody-antigen complex
should disrupt the normal function of the tick protein. In our
study, the hypothesis was that the genes encoding for functionally
important secreted proteins that are highly represented in both L
and SG would result in good candidate tick protective antigens.
These antigens should fulfill the above conditions (a–c) as
abundant functionally important secreted proteins would be
highly exposed to host antibodies and their interaction should
affect protein function, and thus tick feeding and/or development
and pathogen infection and transmission.
To fulfill these criteria, an algorithm was developed using
a vaccinomics approach to tick protective antigen discovery
(de la Fuente and Merino, 2013: de la Fuente et al., 2016).
The algorithm included the generation of transcriptomics
and proteomics data in tick L and SG, and selection of
gene transcripts and proteins highly represented in both
samples and encoding for predicted functionally important
secreted proteins. The initial dataset was obtained from
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FIGURE 4 | Characterization of candidate tick protective antigens. The 4 I. ricinus and 9 D. reticulatus candidate protective antigens were selected after vaccination
trial in rabbits with vaccine E > 40%. (A) The histidine-tagged recombinant proteins were produced using the pET101/D-TOPO expression vector in E. coli BL21
Star (DE3) cells. After induction of gene expression with IPTG, collected cells were disrupted and the insoluble protein fraction containing the recombinant antigens
as inclusion bodies were collected by centrifugation and purified by affinity to 16 polyhistidine. The eluted fraction containing the purified denatured proteins was
dialyzed and concentrated by ultrafiltration to 0.5 mg/ml. Ten µg of purified recombinant antigens were separated by SDS-12% polyacrylamide gel electrophoresis
and stained with Coomassie blue. Arrows indicate the position of recombinant antigens based on the predicted molecular weight. (B) The mRNA levels of selected
genes coding for most effective vaccine antigens in dogs were determined by real-time RT-PCR in tick salivary glands and larvae (IDs refer to annotations in
Tables 1–3). The mRNA levels were normalized against tick rps4 and normalized Ct values (Ave+SD) were compared between salivary glands and larvae by
Student’s t-test with unequal variance (∗P < 0.05; N = 3 biological replicates). (C) Western blot analysis of selected recombinant proteins and Subolesin as negative
control using pooled sera from vaccinated dogs collected at T3. Selected proteins were those corresponding to the most effective protective antigens with vaccine
E > 80%. Arrows indicate the position of recombinant antigens. MW, molecular weight marker.
I. ricinus because of the availability of the I. scapularis
genome sequence for data mining (Gulia-Nuss et al.,
2016). Genes selected in I. ricinus as encoding for tick
candidate protective antigens (Table 1) were then used to
find orthologous genes in D. reticulatus (Table 2). Tick IL
and ISG were selected to cover both initial (larvae) and final
(adult) developmental stages and tissues that are essential for
pathogen acquisition and transmission, respectively (Ayllón
et al., 2015; Chmelaø et al., 2016; Nuttall, 2018). I. ricinus
and D. reticulatus acquire infection when larvae feed on
infected hosts and after transtadial transmission, pathogen
is secreted from salivary glands during feeding of nymph
and adult ticks. Therefore, affecting these two developmental
stages should reduce both tick infestations and pathogen
infection/transmission.
Selection of I. ricinus Candidate
Protective Antigens
After RNAseq, the number of reads/sample corresponded to
27.7 and 27.2 millions for IL and ISG, respectively. Of them,
5,731,608 and 7,024,484 corresponded to pass filter high quality
reads aligned to IL and ISG samples, respectively. Of the
23,297 identified gene transcripts, 49% were included in the
analysis and not discarded due to not enough alignment,
high complexity or shallowly sequenced (Figure 1A and
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FIGURE 5 | Immune IgG antibody response in vaccinated rabbits and dogs. An indirect ELISA test was performed to detect IgG antibodies against recombinant
antigens in serum samples from vaccinated and control (A) rabbits and (B) dogs. Blood samples were collected from each animal before immunization (T1 and T2)
and tick infestation (T3), and at day 75 (T4) in dogs. Serum samples or PBS as negative control were diluted at the optimal dilution of 1:10,000 (v/v). Antibody levels
in vaccinated and control animals were expressed as the OD450nm (ODanimalsera–ODPBScontrol ) and compared between vaccinated and control groups by ANOVA test
(∗P < 0.05). IDs refer to annotations in Tables 1–3.
Supplementary Dataset 1). Of them, 13% were expressed
in IL or ISG only and 18% were overexpressed on either
tissue, but most of the identified genes (70%) did not show
differential expression between IL and ISG (Figure 1A and
Supplementary Dataset 1).
Genes encoding for secreted proteins were predicted using
different algorithms. Predictor’s performance was different with
a total of 1,042 genes predicted as encoding for secreted
proteins (Figure 1B). Protein Prowler performed rather poor
(269 predicted proteins) and almost all of them (259 proteins)
were identical to those predicted by TargetP. CELLO predicted
a low number of secreted proteins. Moreover, it predicted as
many as twelve different subcellular localizations, which made
the results difficult to analyze. Therefore, the results from
Protein Prowler and CELLO were discarded. Five hundred
and one genes were selected as encoding for secreted proteins
(Supplementary Dataset 2). These genes were predicted by at
least two predictors. Of them, 208 (41%) were overexpressed
in ISG and 97 (19%) were among the top 1,000 expressed
genes in both IL and ISG with 6 of them overexpressed in
IL (Supplementary Dataset 2). These 6 genes were selected as
encoding for candidate tick protective antigens (Figure 2 and
Table 1).
A total of 3,454 and 2,339 proteins were identified in
the Ixodidae database in IL and ISG, respectively. Of them,
after applying XCorr > 2, a total of 370 and 367 proteins
were identified in IL and ISG, respectively (Figure 1C and
Supplementary Dataset 3). An additional selection criterion
using FDR ≤ 0.01 and protein identification with at least 4
peptides resulted in the selection of 21 and 11 proteins in
IL and ISG, respectively (Figure 2). Finally, after filtering for
redundant biological function, 3 genes were selected from IL
as encoding for candidate tick protective antigens (Figure 2
and Table 1). The search against the database of predicted
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secreted proteins encoded by the selected top 1,000 expressed
genes in both IL and ISG (Supplementary Dataset 4) using
XCorr > 2 and sequence span > 2% resulted in the identification
of 6 and 10 proteins in IL and ISG, respectively that were
selected as candidate tick protective antigens (Figure 2 and
Table 1).
The GO analysis of transcriptomics data resulted in different
BP for genes predicted as encoding for secreted proteins that were
either overexpressed in ISG or among the top 1,000 expressed
genes in both IL and ISG (Figures 1D,E). In genes highly
expressed in both IL and ISG, metabolic processes was the most
represented (27%) BP (Figure 1D). In genes overexpressed in
ISG, transmembrane transport (23%) and metabolic processes
(17%) were the most represented BP (Figure 1E). Genes in the
signal peptide processing BP (Figure 1D) and transmembrane
transport (Figure 1E) were filtered for highly similar sequences
and resulted in 11 genes (9 overexpressed in ISG and 2
highly expressed in both IL and ISG) that were selected as
encoding for candidate tick protective antigens (Figure 2 and
Table 1).
Finally, GO analysis for BP, MF and CC was conducted
for the selected 36 genes encoding for candidate protective
antigens (Figure 2 and Table 1). The results showed that approx.
40% of genes had unknown BP and MF (Figures 1F,G). As
predicted, most of the genes (95%) encoded for membrane
and secreted proteins, but two genes (ID Nos. 752 and
178) encoded for predicted nuclear DNA-binding proteins
TABLE 3 | Results of the vaccination trials in dogs.
Gene ID DN (%) DMA (%) DT (%) DWA (%) DO (%) DF (%) E (%)
I. ricinus
082 6 0 0 0 0 0 6
216 20 5 33 5 0 67 83∗
391 37 33 9 0 49 68 94∗
749 0 0 0 0 0 0 0
D. reticulatus
S2 40 41 0 22 69 0 89∗
S8 64 60 0 0 63 0 95∗
S10 10 9 0 1 71 0 76
S12 11 12 0 0 65 9 75
S14 0 0 0 0 75 0 75
S16 0 0 0 0 60 0 60
S17 41 50 11 0 43 0 85∗
S18 55 60 0 0 43 4 90∗
S20 55 63 0 6 67 14 95∗
The number of engorged nymphs and adult females, weight/female, oviposition
(egg mass/tick), fertility (No. hatching larvae), and number of nymphs molting
to adults were evaluated. Vaccine efficacy (E) was calculated as E (%) = 100
[1−(DN × DMA × DT × DO × DF)], where DN is the reduction in the number
of engorged nymphs, DMA is the reduction in the number of nymphs molting to
adults, DT is the reduction in the number of engorged female ticks, DO is the
reduction in oviposition, and DF is the reduction in fertility in ticks fed on vaccinated
rabbits when compared to the controls fed on adjuvant/saline injected dogs. Only
parameters with statistically significant differences (P < 0.05) were included in E
calculation. All results are shown in Supplementary Dataset 6. ∗Antigens with
vaccine E > 80% were selected as the most effective tick protective antigens.
(Figure 1H). Although these two genes were initially
predicted as encoding for secreted proteins, they were
removed from further analysis due to the GO CC prediction
(Figure 2 and Table 1). The most represented BP and MF
corresponded to transmembrane transport (22%; Figure 1F)
and transporter activity (28%; Figure 1G), respectively.
Additionally, BP involved in development (8%), reproduction
(oogenesis and oviposition; 6%), protein secretion (signal
peptide processing; 3%) and immunity (3%) were also
represented (Figure 1F).
The final set of genes coding for I. ricinus tick candidate
protective antigens included 34 candidates (Figures 2, 3, Table 1,
and Supplementary Dataset 4).
Selection of D. reticulatus Candidate
Protective Antigens
The number of reads/sample corresponded to 21.7 millions
for DL and 21.8 millions for DSG. The 21,838,507 reads
(∼2.2 Gb) in DSG were compared against the selected
set of I. ricinus genes encoding for candidate protective
antigens (Table 1), clustered and assembled to produce a
set of contigs with homology to selected reference genes.
These contigs were then analyzed for differential expression
between DL and DSG samples and compared to results in
I. ricinus (Table 2). The results showed that 16/27 (59%)
of D. reticulatus genes had an expression pattern similar to
I. ricinus (Table 2).
A total of 268 and 372 proteins were identified in the Ixodidae
database in DL and DSG, respectively, and all remained after
data filtering (Figure 1C and Supplementary Dataset 3). The
additional selection criteria using FDR ≤ 0.01 and protein
identification with at least 4 peptides did not produce new
candidate tick protective antigens.
As previously described for I. ricinus, two genes (IDs S3
and S4) were removed from further analysis due to the GO
CC prediction (Figure 2 and Tables 1, 2). Therefore, the
final set of genes coding for D. reticulatus tick candidate
protective antigens included 25 candidates (Figure 3, Table 2, and
Supplementary Dataset 4).
Selection of Tick Protective Antigens
After Vaccination Trials in Rabbits and
Dogs
Of the selected genes encoding for I. ricinus (N = 34) and
D. reticulatus (N = 25) tick protective antigens, only 16 and 21
respectively were produced as recombinant proteins for initial
vaccination screening in rabbits (Figure 3 and Tables 1, 2).
Of them, 11 were identified in both tick species (Figure 3).
After rabbit vaccination and infestation with I. ricinus or
D. reticulatus tick larvae, the criteria for the final selection
of tick protective antigens for vaccination trials in dogs was
based on vaccine E > 40%. Selection criteria need to be
applied in order to move forward in the vaccinomics pipeline
of selecting candidate protective antigens, and E > 40% was
set as the minimum vaccine E for tick larvae. The selection
of tick protective antigens resulted in 4 I. ricinus and 9
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FIGURE 6 | Summary representation of subcellular localization, function and vaccine efficacy of the selected protective antigens after vaccination trial in dogs.
Complete GO annotations are in Supplementary Dataset 4, and the results of the vaccination trial in rabbits and dogs are in Table 3 and Supplementary
Dataset 6. The I. ricinus antigens 216 and 391, and the D. reticulatus antigens S8, S17, S18 and S20 were identified in the membrane fraction derived from
D. reticulatus and I. ricinus larvae. The effect of vaccination on tick life cycle was based on the parameters used to calculate vaccine E in rabbits and dogs, where DL
is the reduction in the number of engorged larvae, DMN is the reduction in the percent of larvae molting to nymphs, DN is the reduction in the number of engorged
nymphs, DMA is the reduction in the number of nymphs molting to adults, DT is the reduction in the number of engorged female ticks, DO is the reduction in
oviposition, and DF is the reduction in fertility in ticks fed on vaccinated animals when compared to the controls fed on adjuvant/saline injected animals. Only
parameters with statistically significant differences were included in vaccine E calculation.
D. reticulatus antigens (Figure 3, Table 3, and Supplementary
Dataset 6). Of them, 3 were identified in both tick species
(Figure 3). The results in dogs showed that vaccination with
I. ricinus antigens affected different tick developmental stages
(Supplementary Dataset 6) and resulted in an overall vaccine
E > 80% for gene antigens 216 and 391 (Figure 3 and
Table 3). Vaccination with D. reticulatus antigens mainly affected
nymph feeding and molting and oviposition (Supplementary
Dataset 6) with an overall vaccine E ranging from 75 to
95% (Figure 3 and Table 3). Finally, based on the criteria of
vaccine E > 80%, which is considered a good vaccine E for
selection of candidate protective antigens, the I. ricinus 216
and 391 and the D. reticulatus S2, S8, S17, S18, and S20 were
identified as the most effective tick protective antigens (Figure 3
and Table 3).
Characterization of Identified Tick
Protective Antigens
The candidate protective antigens were produced in E. coli and
showed a molecular weight similar to that predicted by the amino
acid sequence composition (Figure 4A and Supplementary
Dataset 5). The mRNA levels of selected genes coding for the
most effective protective antigens were determined by real-time
RT-PCR and confirmed the results of the transcriptomics analysis
(Figure 4B and Tables 1, 2).
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The immunogenicity of candidate protective antigens
(Table 3) was characterized by Western blot (Figure 4C) and
indirect ELISA (Figures 5A,B) tests. The results supported the
antigen-specific antibody response in vaccinated animals, and
except for S2 and S8 antigens the background IgG levels were
low in rabbits (Figure 5A). However, in dogs the background
IgG levels before vaccination at T1 were higher than in
rabbits (Figure 5B), suggesting host-specific differences in
IgG affinity for tick antigens, and/or possible previous tick
infestations at least in some of these dogs. Nevertheless, the
IgG antibody response increased in response to vaccination
in both rabbits and dogs, and for most antigens remained
higher than in control animals until the end of the experiment
(Figures 5A,B).
Focusing on the selected tick protective antigens after
vaccination trials in dogs (Table 3), the I. ricinus antigens
216 and 391, and the D. reticulatus antigens S8, S17, S18
and S20 were identified in the membrane fraction derived
from D. reticulatus and I. ricinus larvae (Figure 6 and
Tables 1, 2), thus confirming the prediction of the algorithms
used for selection of membrane/secreted antigens. These
antigens showed an effect on different tick developmental
stages (Figure 6).
Among these proteins, I. ricinus 216 and D. reticulatus S20
are uncharacterized secreted proteins (Figure 6). However, heme
lipoproteins such as I. ricinus 391 has been proposed as candidate
vaccine protective antigens as being among the most abundant
proteins involved in heme transport from hemolymph to tissues
to complement the loss of the heme synthesis pathway in ticks
(Braz et al., 1999; Maya-Monteiro et al., 2000; Lara et al., 2003,
2005; Hajdusek et al., 2009; Kluck et al., 2018). In agreement with
this function, vaccination with 391 affected all the developmental
stages during I. ricinus life cycle (Figure 6).
In D. reticulatus, a glypican-like protein S8 was identified
(Figure 6). Glypicans have been used for cancer vaccines
against hepatocellular carcinoma (Sun et al., 2016; Li et al.,
2018), but not as protective antigens against ectoparasites or
vector-borne pathogens. Glypicans are a group of cell-surface
glycoproteins involved in the regulation of cellular morphology,
growth, motility and differentiation (Li et al., 2018). The results
of the vaccination trials suggested that these proteins might
play a role in oviposition and development of immature tick
stages (Figure 6).
The D. reticulatus secreted protein S17 was annotated as
involved in homophilic cell adhesion via plasma membrane
adhesion molecules and axon guidance (Figure 6). Proteins with
cell-cell adhesion have a role in immune response and neuronal
wiring, and are highly conserved across evolution (Samanta and
Almo, 2015; Jin and Li, 2019). This protein family has been
recently identified in ticks (Jin and Li, 2019), and our results
suggested a role for this protein in all tick developmental stages
except egg fertility (Figure 6).
Sulfate/anion exchanger molecules such as D. reticulatus
S18 function as transmembrane transporters and are involved
in different biological processes including regulation of blood
pressure (Wall, 2016). Vaccination with this antigen affected
larval and nymphal developmental stages, oviposition and
fertility, suggesting a still uncharacterized function of this protein
during these developmental processes (Figure 6).
The only protein with subcelllular localization in the
endoplasmic reticulum (ER) was the D. reticulatus S2 antigen
(Figure 6). This protein was annotated as a signal peptidase
complex subunit 3, which is involved in protein targeting to ER
through signal peptide processing. The disruption of the catalytic
subunit of these conserved proteins leads to cell death in yeast
(Bohni et al., 1988; Fang et al., 1997), Plasmodium falciparum
(Tuteja et al., 2008), and Leishmania manilensis major (Taheri
et al., 2010). Furthermore, knockdown by RNA interference
of the gene coding for this enzyme in Locusta migratoria
(LmSPC1) affected insect molting, feeding, reproduction and
embryonic development (Zhang and Xia, 2014). Vaccination
with this antigen reduced development of tick immature stages
and oviposition, supporting the role of this protein in tick
survival (Figure 6).
CONCLUSION
The experimental approach used in this study resulted in the
identification of tick protective antigens by using a vaccinomics
approach in combination with vaccination trials. Based on
the criteria of vaccine E > 80%, two I. ricinus and five
D. reticulatus proteins were identified as the most effective
protective antigens (Figure 6). Consequently, these antigens were
proposed for commercial vaccine development for the control
of tick infestations in companion animals, and other hosts for
these tick species.
The putative function of selected protective antigens, which
are involved in different biological processes, resulted in vaccines
affecting multiple tick developmental stages (Figure 6). These
results suggested that the combination of some of these antigens
might be considered to increase vaccine efficacy through antigen
synergy for the control of tick infestations and potentially
affecting pathogen infection and transmission.
Finally, additional facts should be considered for vaccine
development including that (a) a protective antigen is necessary
but not sufficient for an effective vaccine as vaccine formulation,
adjuvant and antigen composition including tick-derived and
pathogen-derived antigens highly influence the final vaccine
efficacy, (b) tick vaccines cannot be designed to prevent
tick attachment and feeding because the immune response
to vaccination (e.g., antibodies) needs to interact with target
antigens in order to have an effect on different biological
processes affecting life cycle of ticks and transmitted pathogens,
(c) tick vaccines for wild animals are difficult to deliver, but
appropriate vaccine formulations (i.e., virus-based) may address
this problem, and (d) vaccines for companion animals may be
acceptable if they increase animal welfare and health by reducing
the duration of tick feeding and pathogen transmission.
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